4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2017 |
| Reihe/Periodikum: | Allergy, Asthma & Clinical Immunology ; volume 13, issue 1 ; ISSN 1710-1492 |
| Verlag/Hrsg.: |
Springer Science and Business Media LLC
|
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-29050530 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | http://dx.doi.org/10.1186/s13223-017-0206-9 |
